Strong Balance Sheet Stocks

Results

1722

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

1722 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	6652	NT$1.96	0%	-67.7%	NT$268.5m	n/a	129.3	n/a	n/a	Pharmaceuticals & Biotech
	6138	NT$358.50	14.5%	121.3%	NT$26.7b	n/a	25.9	n/a	3.1%	Semiconductors
	6668	NT$47.20	24.0%	-0.1%	NT$5.1b	NT$40.00	4.2	20.9%	0%	Capital Goods
	3006	NT$237.50	9.4%	317.4%	NT$67.4b	n/a	28.3	n/a	0.4%	Semiconductors
	6474	NT$37.90	-0.5%	-7.7%	NT$2.0b	n/a	12.6	n/a	5.3%	Capital Goods
	6113	NT$28.40	4.2%	13.1%	NT$1.5b	n/a	2.1	n/a	1.8%	Tech
	8284	NT$64.80	2.4%	-6.6%	NT$3.0b	n/a	14.2	n/a	6.2%	Software
	4194	NT$7.23	0.7%	18.5%	NT$1.1b	n/a	5.8	n/a	n/a	Pharmaceuticals & Biotech
	2755	NT$138.50	2.2%	17.6%	NT$5.1b	NT$168.00	20.8	n/a	2.5%	Consumer Services
	4561	NT$42.50	1.1%	-6.9%	NT$2.5b	n/a	66.3	n/a	0.5%	Capital Goods
	2723	NT$66.90	-1.0%	-21.4%	NT$12.0b	NT$85.00	0.7	67.4%	0%	Consumer Services
	2812	NT$19.80	1.5%	0.7%	NT$119.2b	n/a	1.3	n/a	2.0%	Banks
	2033	NT$15.75	0.3%	-8.4%	NT$1.3b	n/a	47.6	n/a	1.3%	Materials
	2368	NT$1,355.00	2.7%	408.4%	NT$684.8b	NT$1,485.00	60.4	38.2%	0.7%	Tech
	4178	NT$17.65	-0.8%	-28.0%	NT$3.8b	n/a	10.7	-6.2%	n/a	Pharmaceuticals & Biotech
	3023	NT$327.50	4.3%	49.9%	NT$78.6b	NT$342.00	25.6	21.2%	3.1%	Tech
	6617	NT$67.60	-1.7%	-29.6%	NT$8.3b	n/a	216.5	n/a	n/a	Pharmaceuticals & Biotech
	6986	NT$57.00	-5.9%	-21.2%	NT$2.6b	n/a	23.4	n/a	0.4%	Pharmaceuticals & Biotech
	5478	NT$106.50	3.9%	0.5%	NT$15.9b	n/a	12.0	n/a	4.7%	Media
	1472	NT$91.00	0.7%	-0.9%	NT$4.8b	n/a	14.2	n/a	6.6%	Capital Goods
	1612	NT$38.30	1.6%	-0.3%	NT$12.1b	n/a	12.8	n/a	6.5%	Capital Goods
	3563	NT$715.00	1.3%	39.0%	NT$45.7b	NT$1,200.00	45.6	38.8%	1.8%	Semiconductors
	9905	NT$21.05	1.0%	-7.7%	NT$6.4b	n/a	14.9	n/a	5.2%	Materials
	3338	NT$75.20	1.5%	48.0%	NT$6.6b	n/a	51.8	n/a	1.7%	Tech

Page 1 of 48